Biphasic (68)Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.

PURPOSE - Binding of (68)Ga-PSMA-HBED-CC ((68)Ga-PSMA) at prostate cancer (PC) cells increases over time. A biphasic protocol may help separating benign from tumor lesions. The aim of this study was the retrospective evaluation of a diagnostic incremental value of a dual-time point (biphasic) (68)Ga-PSMA-PET/CT in patients with prostate cancer.

METHODS - Retrospective analysis of 35 consecutive patients (49-78 years, median 71) with newly diagnosed PC (12/35) or recurrence of PC (23/35). PET/CT (Gemini TF16, Philips) was acquired 1 h and 3 h p. i. of 140-392 MBq (300 MBq median) (68)Ga-PSMA, followed by a diagnostic contrast CT. PET findings were correlated with histology or unequivocal CT findings. Semiquantitative PET data (SUVmax, SUV mean) were acquired and target-to-background-ratios (T/B-ratio) were calculated for benign and malign lesions for both time points. Size of lymph nodes (LN) on diagnostic CT was recorded. Statistical analysis was performed for assessment of significant changes of semiquantitative PET-parameters over time and for correlation of size and uptake of lymph nodes.

RESULTS - One hundred and four lesions were evaluated. Sixty lesions were referenced by histology or unequivocal CT findings, including eight (13. 3 %) histopathologically benign lymph nodes, 12 (20 %) histopathologically lymph node metastases, 12 (20 %) primary tumors, three (5 %) local recurrences, and 25 (41. 7 %) bone metastases. Forty-four lesions were axillary LN with normal CT-appearance. Benign lesions had significantly lower SUVmax and T/B-ratios compared with malignant findings. Malign lesions showed a significant increase of both parameters over time compared to benign findings. There was no correlation between LN size and SUVmax. The sensitivity, specificity, the positive predictive value and negative predictive value of PET/CT regarding pelvic LN was 94 %, 99 %, 89 %, and 99. 5 %, respectively.

CONCLUSIONS - In contrast to benign tissues, the uptake of proven tumor lesions increases on (68)Ga-PSMA-PET/CT over time. A biphasic PET-study may lead to a better detection of tumor lesions in unequivocal findings.

European journal of nuclear medicine and molecular imaging. 2015 Nov 12 [Epub ahead of print]

Carsten-Oliver Sahlmann, Birgit Meller, Caroline Bouter, Christian Oliver Ritter, Philipp Ströbel, Joachim Lotz, Lutz Trojan, Johannes Meller, Sameh Hijazi

Department of Nuclear Medicine, University Medical Center Goettingen, Robert-Koch-Str. 40, D-37075, Goettingen, Germany. Department of Nuclear Medicine, University Medical Center Goettingen, Robert-Koch-Str. 40, D-37075, Goettingen, Germany. Department of Nuclear Medicine, University Medical Center Goettingen, Robert-Koch-Str. 40, D-37075, Goettingen, Germany. Department of Diagnostic and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany. Department of Pathology, University Medical Center Goettingen, Goettingen, Germany. Department of Diagnostic and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany. Department of Urology, University Medical Center Goettingen, Goettingen, Germany. Department of Nuclear Medicine, University Medical Center Goettingen, Robert-Koch-Str. 40, D-37075, Goettingen, Germany. Department of Urology, University Medical Center Goettingen, Goettingen, Germany. 

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe